Single-tablet regimens for HIV

From IDWiki
Revision as of 18:05, 11 August 2019 by Maintenance script (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Single-tablet regimens

See also [HIV treatment](HIV treatment.md)

Brand name NRTIs Non-NRTI Notes
Triumeq abacavir / lamivudine dolutegravir (INI) Highest barrier to resistance. Need to test for HLA-B5701 allele before starting. Avoid in hepatitis B coinfection.
Atripla tenofovir disoproxil / emtricitabine efavirenz Older regimen. Neuropsychiatric symptoms, possibly including suicide.
Complera tenofovir disoproxil / emtricitabine rilpivirine Avoid with viral loads (>100,000) or low CD4 (<200). Pill must be taken with food (>400kcal) and without PPIs.
Stribild tenofovir disoproxil / emtricitabine elvitegravir/cobicistat (INI) Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70.
Biktarvy FTC/TAF BIC